3 FDA Legal Traps When Marketing your Dietary Supplement Product

Learn how to avoid these FDA legal traps when marketing your dietary supplement product.

7 Legal Keys to Getting Your OTC Drug to Market

Wondering how to get your OTC drug to market? This FDA OTC drug primer tells you how.

10 Legal Tips to Stop FDA from Classifying Your Dietary Supplement as a Drug

Your dietary supplement products could be regulated as a new drug by FDA, unless you pay attention to these regulatory fundamentals.

The Shocking Truth About FDA Dietary Supplement Labeling: 3 Things You Must Know

As they say in Game of Thrones, “Winter is Coming.” It’s a grim statement that reminds everyone that ahead is nothing but snow and ice. When you’re preparing to launch your dietary supplement [...]

Physicians & Healthcare Startups: Don’t Mess with Alphabet-Soup Lettered Government Agencies

Physicians and healthcare startups beware of FDA, FTC, and medical board liability: what you don’t know.

5 Mistakes in Dietary Supplement Labeling that Could Land you in FDA or FTC Enforcement Trouble

Many of our dietary supplement companies come to us with various mistaken assumptions with respect to labeling their dietary supplement products. Let’s talk about 5 key dietary supplement [...]

5 Ways Cosmetic Product Companies Can Comply with FDA Labeling Requirements & Help Avoid FDA Enforcement.

Cosmetic products do not require Food and Drug Administration (FDA) approval unless they have color additives or unless the qualify as a drug, medical device, or dietary supplements. There are [...]

How to Respond to an FDA Warning Letter about Dietary Supplements or Cosmetics

The United States Food and Drug Administration (FDA) regulates much more than food and drugs. It regulates dietary supplements, cosmetics, medical devices, tobacco products, animal food, [...]

FDA Dietary Supplement Labeling Requirements: Comply or Die

FDA labeling is one of the most important regulatory requirements for dietary supplements in that it provides the consumer the necessary information on the product. Indeed, ensuring that all [...]

FDA Signals Tough New Regulatory Stance on Homeopathic Drugs

FDA is changing the playing field by withdrawing its earlier Compliance Policy Guide (CPG) 400.400, Conditions Under Which Homeopathic Drugs May be Marketed, and issuing its new draft Guidance on [...]